PAPER Vázquez-Higuera JL, Mateo I, Sánchez-Juan P, Rodríguez-Rodríguez E, Pozueta A, Calero M, Dobato JL, Frank-García A, Valdivieso F, Berciano J, Bullido MJ, Combarros O
SEARCH RESULTS
331209 RESULTS
PAPER de Wilde MC, Penke B, van der Beek EM, Kuipers AA, Kamphuis PJ, Broersen LM
Neuroprotective effects of a specific multi-nutrient intervention against Aβ42-induced toxicity in rats.
J Alzheimers Dis. 2011;27(2):327-39. PubMed: 21811020PAPER Takasaki J, Ono K, Yoshiike Y, Hirohata M, Ikeda T, Morinaga A, Takashima A, Yamada M
Vitamin A has anti-oligomerization effects on amyloid-β in vitro.
J Alzheimers Dis. 2011;27(2):271-80. PubMed: 21811022PAPER Koutras C, Lessard CB, Lévesque G
A nuclear function for the presenilin 1 neuronal partner NPRAP/δ-catenin.
J Alzheimers Dis. 2011;27(2):307-16. PubMed: 21811021PAPER Schroeter ML, Neumann J
Combined Imaging Markers Dissociate Alzheimer's Disease and Frontotemporal Lobar Degeneration- An ALE Meta-Analysis.
Front Aging Neurosci. 2011;3:10. PubMed: 21811457PAPER Westman E, Cavallin L, Muehlboeck JS, Zhang Y, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO,
Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease.
PLoS One. 2011;6(7):e22506. PubMed: 21811624PAPER Sims R, Dwyer S, Harold D, Gerrish A, Hollingworth P, Chapman J, Jones N, Abraham R, Ivanov D, Pahwa JS, Moskvina V, Dowzell K, Thomas C, Stretton A, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuiness B, Todd S, Johnston JA, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Hardy J, Mead S, Fox N, Rossor M, Collinge J, Livingston G, Bass NJ, Gurling H, McQuillin A, Jones L, Holmans PA, O'Donovan M, Owen MJ, Williams J
No evidence that extended tracts of homozygosity are associated with Alzheimer's disease.
Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(7):764-71. PubMed: 21812096PAPER Schaeffer EL, Figueiro M, Gattaz WF
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models.
Clinics (Sao Paulo). 2011;66 Suppl 1:45-54. PubMed: 21779722PAPER Niedermeyer E, Ghigo JO
Alzheimer dementia: an overview and a promising new concept.
Am J Electroneurodiagnostic Technol. 2011 Jun;51(2):82-91. PubMed: 21809745PAPER Mancuso C, Siciliano R, Barone E, Butterfield DA, Preziosi P
Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.
Expert Opin Investig Drugs. 2011 Sep;20(9):1243-61. PubMed: 21810032PAPER Erk S, Spottke A, Meisen A, Wagner M, Walter H, Jessen F
Evidence of neuronal compensation during episodic memory in subjective memory impairment.
Arch Gen Psychiatry. 2011 Aug;68(8):845-52. PubMed: 21810648PAPER Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR, Thal L, Aisen PS,
Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.
Arch Gen Psychiatry. 2011 Aug;68(8):853-61. PubMed: 21810649PAPER Choi Y, Marchani EE, Bird TD, Steinbart EJ, Blacker D, Wijsman EM
Genome scan of age-at-onset in the NIMH Alzheimer disease sample uncovers multiple loci, along with evidence of both genetic and sample heterogeneity.
Am J Med Genet B Neuropsychiatr Genet. 2011 Dec;156B(7):785-98. PubMed: 21812099PAPER Rice SA, Talcott RE
Effects of isoniazid treatment on selected hepatic mixed-function oxidases.
Drug Metab Dispos. 1979 Sep-Oct;7(5):260-2. PubMed: 40762Paris: Beyond Genomics, French Science Draws on Populations, Patients
CONFERENCE COVERAGE 2011-08-04 Conference Coverage As might be expected, there was a potpourri of French AD science at the Alzheimer’s Association International Conference (AAIC), held 16-21 July 2011 in Paris. One French research initiative par excellence, highlighted in Part 1 of thi
Current Filters
No filters selected